Steel Partners Holdings L.P. Issues Open Letter to All InMode Stakeholders and Sets October 30, 2026 Expiration for Its $16.75 Per Share All-Cash OfferBusiness Wire · 5 days ago
InMode to Report Third Quarter 2026 Financial Results on November 11, 2026, Expects Third Quarter Revenue of $91.8 Million to $92.0 Million, Reiterates FY 2026 Revenue Guidance Between $365M-$375MPRNewsWire · Oct 13, 2026
Contrasting PAVmed (NASDAQ:PAVM) and InMode (NASDAQ:INMD)Defense World · Oct 8, 2026
InMode: Hope Is Not An Effective Investment Strategy, But Neither Is DespairSeeking Alpha · Sep 25, 2026
Reviewing InMode (NASDAQ:INMD) & LogicMark (OTCMKTS:LGMKD)Defense World · Sep 24, 2026
Financial Analysis: IDEXX Laboratories (NASDAQ:IDXX) vs. InMode (NASDAQ:INMD)Defense World · Sep 11, 2026InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 5, 2026 | $0.35 | $0.35 | Beat |
| May 6, 2026 | $0.30 | $0.25 | Miss |
| Feb 10, 2026 | $0.42 | $0.46 | Beat |
| Nov 5, 2025 | $0.35 | $0.38 | Beat |
| Jul 30, 2025 | $0.43 | $0.47 | Beat |
| Apr 28, 2025 | $0.33 | $0.31 | Miss |